of February 11, 2015 No. 19
About establishment of the republican list of the drugs, psychotropic substances and their precursors which are subject to the state control in the Republic of Belarus
Based on part one of Item 15 of the Decree of the President of the Republic of Belarus of December 28, 2014 "About urgent measures for counteraction to drug trafficking" and subitem 9.1 of Item 9 of the Regulations on the Ministry of Health of the Republic of Belarus approved by the resolution of Council of Ministers of the Republic of Belarus of October 28, 2011 No. 1446 "About some questions of the Ministry of Health and measures for implementation of the Presidential decree of the Republic of Belarus of August 11, 2011 No. 360" the Ministry of Health of the Republic of Belarus DECIDES: No. 6
1. Establish the republican list of the drugs, psychotropic substances and their precursors which are subject to the state control in the Republic of Belarus according to appendix.
2. This resolution becomes effective after its official publication.
Minister |
V.I.Zharko |
It is approved Minister of Internal Affairs of the Republic of Belarus February 10, 2015 |
I. A. Shunevich |
It is approved Chairman of the State committee of judicial examinations of the Republic of Belarus major general of justice February 10, 2015 |
A.I.Shved |
Appendix
to the Resolution of the Ministry of Health of the Republic of Belarus of February 11, 2015 No. 19
List 1
especially dangerous drugs and psychotropic substances which are not used in the medical purposes
№ |
International unregistered names or other unscientific names |
Chemical structure or short description |
1.1 |
Drugs: |
|
1.1.1 |
AH-7921 |
N-{ [1 (dimethylamines) cyclohexyl] marked } - 3,4 - dichlorbenzamide |
1.1.1-1 |
MT-45 |
1-(1,2-difeniletil) - 4 cyclohexylpiperazin |
1.1.1-2 |
W-15 |
N-[1-(2-feniletit) piperidine-2-илиден] - 4-hlorbenzolsulfonamid |
1.1.1-3 |
W-18 |
N-{ 1-[2-(4 nitrophenyl) ethyl] пиперидин-2-илиден}-4-хлорбензолсульфонамид |
1.1.1-4 |
7-Atsetoksimitraginin |
methyl-2 (-7a-ацетокси-8-метокси-3-этил-1,2,3,4,6,7,7a,12b-октагидроиндоло [2,3-a] quinolizine-2-silt) - 3-metoksiakrilat |
1.1.2 |
Bezitramide |
4-[4-(2-оксо-3-пропионил-2,3-дигидро-1H-бензимидазол-1-ил) piperidine-1-silt] - 2, 2-difenilbutannitrit; |
1.1.2-1 |
Brorfin |
1-{ 1-[1-(4-bromfenit) ethyl] пиперидин-4-ил}-1,3-дигидро-2H-бензимидазол-2-он |
1.1.3 |
7-Gidroksimitraginin |
methyl-2 (-7a-гидрокси-8-метокси-3-этил-1,2,3,4,6,7,7a,12b-октагидроиндоло [2,3-a] quinolizine-2-silt) - 3-metoksiakrilat |
1.1.4 |
Diampromid |
N-{ 2-[(2-feniletit) amine methyl] spent on drink } - N-fenilpropanamid; |
1.1.5 |
Dimenoksadol |
O-[2-(dimethylamine) ethyl] - 2, 2-diphenyl-2-ethoxyacetate; |
1.1.6 |
Methadone intermediate product |
4 (dimethylamines) - 2-difenilpentannitrit 2,; |
1.1.7 |
Mitraginin (9-metoksikorinanteidin) |
methyl-3-metoksi-2 (-8-метокси-3-этил-1,2,3,4,6,7,12,12b-октагидроиндоло [2,3-a] quinolizine-2-silt) acrylate |
1.1.8 |
Pro-heptazine |
1,3-диметил-4-фенил-4-пропаноилоксиазепан; |
1.1.9 |
Fenampromid |
N-[1-(piperidine-1-silt) propane-2-silt] - N-fenilpropanamid; |
1.1. H01 |
Morfinana [basic structure – морфинан]: |
|
1.1. H01.1 |
Atsetildigidrokodein |
6-ацетилокси-17-метил-3-метокси-4,5-эпоксиморфинан; |
1.1. H01.2 |
Atsetorfin |
3-atsetiloksi-7alfa-(1-hydroxy-1-methylbutyl) -17-метил-6-метокси-4,5-эпокси-6,14-эндо-этеноморфинан; |
1.1. H01.3 |
Hydrocodon |
17-метил-3-метокси-4,5-эпоксиморфинан-6-он; |
1.1. H01.4 |
Gidromorfinol |
17-methyl-4,5-epoksimorfinan-3, 6, 14-triol; |
1.1. H01.5 |
Desomorphine |
17-methyl-4,5-epoksimorfinan-3-ol; |
1.1. H01.6 |
Digidromorfin |
17-methyl-4,5-epoksimorfinan-3,6-diol; |
1.1. H01.7 |
Digidroetorfin |
7 alpha (1-hydroxy-1-methylbutyl) -17-метил-6-метокси-4,5-эпокси-6,14-эндо-этаноморфинан-3-ол; |
1.1. H01.8 |
Drotebanol |
17-метил-3,4-диметоксиморфинан-6бета,14-диол; |
1.1. H01.9 |
Kodoksim |
(17-метил-3-метокси-4,5-эпоксиморфинан-6-илиден) aminohydroxyacetic acid; |
1.1. H01.10 |
Levometorfan |
(–) - 17-methyl-3-metoksimorfinan; |
1.1. H01.11 |
Levorphanol |
(–) - 17-metilmorfinan-3-ol; |
1.1. H01.12 |
Levofenatsilmorfan |
(–)-2 (3-gidroksimorfinan-17-silt) - 1-feniletanon; |
1.1. H01.13 |
Metildigidromorfin |
6, 17-dimethyl-4,5-epoksimorfinan-3,6-diol; |
1.1. H01.14 |
Metopon |
3-гидрокси-5,17-диметил-4,5-эпоксиморфинан-6-он; |
1.1. H01.15 |
Nikodikodin |
17-метил-3-метокси-6-(пиридин-3-карбонилокси) - 4, 5-epoksimorfinan; |
1.1. H01.16 |
Norlevorfanol |
(–) - morfinan-3-ol; |
1.1. H01.17 |
Oxymorphone |
3,14-дигидрокси-17-метил-4,5-эпоксиморфинан-6-он; |
1.1. H01.18 |
Ratsemetorfan |
(±)-17-methyl-3-metoksimorfinan; |
1.1. H01.19 |
Ratsemorfan |
(±)-17-metilmorfinan-3-ol; |
1.1. H01.20 |
Fenomorfan |
17-(2-feniletit) morfinan-3-ol; |
1.1. H01.21 |
Etorfin |
7 alpha (1-hydroxy-1-methylbutyl) -17-метил-6-метокси-4,5-эпокси-6,14-эндо-этеноморфинан-3-ол; |
1.1. H02 |
7, 8-didegidromorfinana [basic structure – 7, 8-didegidromorfinan]: |
|
1.1. H02.1 |
Atsetilkodein |
6-ацетилокси-17-метил-3-метокси-4,5-эпокси-7,8-дидегидроморфинан |
1.1. H02.2 |
Benzylmorphine |
3-бензилокси-17-метил-4,5-эпокси-7,8-дидегидроморфинан-6-ол; |
1.1. H02.3 |
Heroin |
3,6 - of di (atsetiloksa) -17-метил-4,5-эпокси-7,8-дидегидроморфинан; |
1.1. H02.4 |
6-Dezoksikodein |
17-метил-3-метокси-4,5-эпокси-7,8-дидегидроморфинан |
1.1. H02.5 |
Mirofin |
3-бензилокси-17-метил-6-тетрадеканоилокси-4,5-эпокси-7,8-дидегидроморфинан; |
1.1. H02.6 |
Monoatsetilmorfin |
3-ацетилокси-17-метил-4,5-эпокси-7,8-дидегидроморфинан-6-ол; |
1.1. H02.7 |
Morfinmetilbromid and other pentavalent nitrogenous derivatives of morphine, including N-oksimorfinovye derivative, one of which N-N-oksikodein |
3,6-дигидрокси-17,17-диметил-4,5-эпокси-7,8-дидегидроморфинаний bromide; |
1.1. H02.8 |
Morphine-N-oxide |
3,6-дигидрокси-17-метил-4,5-эпокси-7,8-дидегидроморфинан-N-оксид; |
1.1. H02.9 |
Nikokodin |
17-метил-3-метокси-6-(пиридин-3-карбонилокси) - 4, 5-epoxy-7,8-didegidromorfinan; |
1.1. H02.10 |
Nicomorphine |
17-метил-3,6-ди(пиридин-3-карбонилокси) - 4, 5-epoxy-7,8-didegidromorfinan; |
1.1. H02.11 |
Norkodein |
3-метокси-4,5-эпокси-7,8-дидегидроморфинан-6-ол; |
1.1. H02.12 |
Normorfin |
4,5-эпокси-7,8-дидегидроморфинан-3,6-диол; |
1.1. H02.13 |
Folkodin |
17-metil-3-[2 (morpholine-4-silt) of etoksa] - 4, 5-epoxy-7,8-didegidromorfinan-6-ol; |
1.1. H03 |
6, 7-didegidromorfinana [basic structure – 6, 7-didegidromorfinan]: |
|
1.1. H03.1 |
Metildezorfin |
6,17-диметил-4,5-эпокси-6,7-дидегидроморфинан-3-ол; |
1.1. H03.2 |
Thabacon |
6-ацетилокси-17-метил-3-метокси-4,5-эпокси-6,7-дидегидроморфинан; |
1.1. H04 |
Tetradegidromorfinana [basic structure – 6,7,8, 14-tetradegidromorfinan]: |
|
1.1. H04.1 |
Oripavin |
17-метил-6-метокси-4,5-эпокси-6,7,8,14-тетрадегидроморфинан-3-ол; |
1.1. H05 |
Fenilpiperidina [basic structure – 4-fenilpiperidin]: |
|
1.1. H05.1 |
Allilprodin |
1-metil-3-(prop-2-en-1-silt) - 4-propanoiloksi-4-fenilpiperidin; |
1.1. H05.2 |
Alfameprodin |
(3S,4R)-1-метил-4-пропаноилокси-4-фенил-3-этилпиперидин; |
1.1. H05.3 |
Alfaprodin |
(3S,4R)-1,3-диметил-4-пропаноилокси-4-фенилпиперидин; |
Disclaimer! This text was translated by AI translator and is not a valid juridical document. No warranty. No claim. More info
Database include more 50000 documents. You can find needed documents using search system. For effective work you can mix any on documents parameters: country, documents type, date range, teams or tags.
More about search system
If you cannot find the required document, or you do not know where to begin, go to Help section.
In this section, we’ve tried to describe in detail the features and capabilities of the system, as well as the most effective techniques for working with the database.
You also may open the section Frequently asked questions. This section provides answers to questions set by users.